These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20890270)

  • 1. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
    Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
    Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
    Long KB; Srivastava A; Hirsch MS; Hornick JL
    Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.
    Haynes CM; Sangoi AR; Pai RK
    Cancer Cytopathol; 2011 Jun; 119(3):193-201. PubMed ID: 21328566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin.
    Koo J; Mertens RB; Mirocha JM; Wang HL; Dhall D
    Mod Pathol; 2012 Jun; 25(6):893-901. PubMed ID: 22388755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors.
    Lai JP; Mertens RB; Mirocha J; Koo J; Venturina M; Chung F; Mendez AB; Kahn M; Dhall D
    Endocr Pathol; 2015 Mar; 26(1):54-62. PubMed ID: 25433656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
    Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
    Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.
    Lorenzo PI; Jimenez Moreno CM; Delgado I; Cobo-Vuilleumier N; Meier R; Gomez-Izquierdo L; Berney T; Garcia-Carbonero R; Rojas A; Gauthier BR
    Histochem Cell Biol; 2011 Nov; 136(5):595-607. PubMed ID: 21932072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1.
    Weissferdt A; Tang X; Wistuba II; Moran CA
    Mod Pathol; 2013 Dec; 26(12):1554-60. PubMed ID: 23787439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
    Lu H; Allende D; Liu X; Zhang Y
    Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
    Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
    Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Ductal Tumors of the Pancreas.
    Dhillon J
    Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
    Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
    J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
    Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
    Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A; Hornick JL
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
    Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
    Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
    Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
    Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and outcome of mixed neuroendocrine non-neuroendocrine neoplasms of the pancreas.
    Nießen A; Schimmack S; Weber TF; Mayer P; Bergmann F; Hinz U; Büchler MW; Strobel O
    Pancreatology; 2021 Jan; 21(1):224-235. PubMed ID: 33309225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
    Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
    Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterparts.
    Bi Y; Deng Y; Li S; Zhou X; Chen Y; Ma D; Mao X; Guan Y; Chen J; Meng Y
    J Surg Oncol; 2016 Nov; 114(6):697-702. PubMed ID: 27761900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.